0000899243-22-031659.txt : 20220922 0000899243-22-031659.hdr.sgml : 20220922 20220922073103 ACCESSION NUMBER: 0000899243-22-031659 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220920 FILED AS OF DATE: 20220922 DATE AS OF CHANGE: 20220922 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pelizzon David R CENTRAL INDEX KEY: 0001719217 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38242 FILM NUMBER: 221257847 MAIL ADDRESS: STREET 1: 2850 FRONTIER DR CITY: WARSAW STATE: IN ZIP: 46582 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ORTHOPEDIATRICS CORP CENTRAL INDEX KEY: 0001425450 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 261761833 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2850 FRONTIER DRIVE CITY: WARSAW STATE: IN ZIP: 46582 BUSINESS PHONE: 574-268-6379 MAIL ADDRESS: STREET 1: 2850 FRONTIER DRIVE CITY: WARSAW STATE: IN ZIP: 46582 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-09-20 0 0001425450 ORTHOPEDIATRICS CORP KIDS 0001719217 Pelizzon David R C/O SQUADRON CAPITAL LLC 18 HARTFORD AVE., PO BOX 223 GRANBY CT 06035 1 0 1 0 Common Stock 2022-09-20 4 X 0 1525000 0.0003 A 6901764 I See footnote Common Stock 24816 D Warrants (right to buy) 0.0003 2022-09-20 4 X 0 1525000 0.00 A Common Stock 1525000 0 I See footnote These securities are held directly by Squadron Capital LLC ("Squadron"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these securities. The reporting person expressly disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein. The inclusion of these securities in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose. Squadron beneficially owns shares of the Issuer's common stock with a market value in excess of the notification threshold of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"). The warrants could not be exercised until the expiration of all applicable HSR Act waiting periods or the exercise otherwise becomes exempt from the notification requirements thereunder. On September 19, 2022, the waiting period under the HSR Act expired. Once the warrants became exercisable, Squadron Capital LLC was obligated to exercise them within five (5) business days. /s/ David R. Pelizzon 2022-09-22